GB0717101D0 - Tumour marker - Google Patents
Tumour markerInfo
- Publication number
- GB0717101D0 GB0717101D0 GBGB0717101.0A GB0717101A GB0717101D0 GB 0717101 D0 GB0717101 D0 GB 0717101D0 GB 0717101 A GB0717101 A GB 0717101A GB 0717101 D0 GB0717101 D0 GB 0717101D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- tumour marker
- tumour
- marker
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
- G01N33/57492—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds localized on the membrane of tumor or cancer cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6854—Immunoglobulins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/77—Internalization into the cell
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/70503—Immunoglobulin superfamily, e.g. VCAMs, PECAM, LFA-3
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0717101.0A GB0717101D0 (en) | 2007-09-03 | 2007-09-03 | Tumour marker |
PCT/GB2008/002954 WO2009030884A2 (en) | 2007-09-03 | 2008-09-01 | Mannosylated butyrophilin tumour markers |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0717101.0A GB0717101D0 (en) | 2007-09-03 | 2007-09-03 | Tumour marker |
Publications (1)
Publication Number | Publication Date |
---|---|
GB0717101D0 true GB0717101D0 (en) | 2007-10-10 |
Family
ID=38617179
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB0717101.0A Ceased GB0717101D0 (en) | 2007-09-03 | 2007-09-03 | Tumour marker |
Country Status (2)
Country | Link |
---|---|
GB (1) | GB0717101D0 (ru) |
WO (1) | WO2009030884A2 (ru) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2478359A4 (en) * | 2009-09-14 | 2013-03-20 | Univ Rockefeller | METHOD FOR IDENTIFYING ANTI-INFLAMMATORY COMPOUNDS |
EP3074040A4 (en) * | 2013-11-29 | 2017-06-28 | CSL Limited | Method of treating cancer |
CN105457024B (zh) * | 2014-10-13 | 2021-03-16 | 李小彦 | 抗butyrophilin-3人源化抗体及其使用 |
WO2016191305A1 (en) * | 2015-05-22 | 2016-12-01 | The Board Of Trustees Of The Leland Stanford Junior University | Btn3a ectodomain proteins and methods of use |
EP3909983A1 (en) * | 2015-12-02 | 2021-11-17 | STCube & Co. Inc. | Antibodies and molecules that immunospecifically bind to btn1a1 and the therapeutic uses thereof |
EP3383908A1 (en) | 2015-12-02 | 2018-10-10 | Stsciences, Inc. | Antibodies specific to glycosylated btla (b- and t- lymphocyte attenuator) |
JP2020522512A (ja) * | 2017-05-31 | 2020-07-30 | ストキューブ アンド シーオー., インコーポレイテッド | Btn1a1に免疫特異的に結合する抗体及び分子を用いて癌を治療する方法 |
JP7369038B2 (ja) * | 2017-05-31 | 2023-10-25 | ストキューブ アンド シーオー., インコーポレイテッド | Btn1a1に免疫特異的に結合する抗体及び分子並びにその治療的使用 |
JP2020522562A (ja) | 2017-06-06 | 2020-07-30 | ストキューブ アンド シーオー., インコーポレイテッド | Btn1a1又はbtn1a1リガンドに結合する抗体及び分子を用いて癌を治療する方法 |
JP7226833B2 (ja) | 2017-09-21 | 2023-02-21 | イムチェック セラピューティクス エスエーエス | Btn2に特異性を有する抗体及びその使用 |
US11098093B2 (en) | 2019-01-07 | 2021-08-24 | Shattuck Labs, Inc. | Heterodimeric proteins for modulating gamma delta T cells |
AU2020205965A1 (en) | 2019-01-07 | 2021-07-01 | Shattuck Labs. Inc. | Heterodimeric proteins for modulating gamma delta T cells |
EP3696191A1 (en) * | 2019-02-14 | 2020-08-19 | Fundación Instituto de Investigación contra la Leucemia Josep Carreras (IJC) | Car t-cells for the treatment of cd1a-positive cancer |
KR20220007041A (ko) * | 2019-03-20 | 2022-01-18 | 임체크 테라퓨틱스 에스에이에스 | Btn2에 대한 특이성을 갖는 항체 및 이의 용도 |
CN114746445A (zh) * | 2019-06-28 | 2022-07-12 | 墨尔本大学 | 抑制或激活γδT细胞的方法 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2007117507A (ru) * | 2004-11-22 | 2008-12-27 | Вайет (Us) | Способы и системы для прогнозирования и лечения солидных опухолей |
-
2007
- 2007-09-03 GB GBGB0717101.0A patent/GB0717101D0/en not_active Ceased
-
2008
- 2008-09-01 WO PCT/GB2008/002954 patent/WO2009030884A2/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2009030884A2 (en) | 2009-03-12 |
WO2009030884A3 (en) | 2009-06-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB0717101D0 (en) | Tumour marker | |
EP2079385A4 (en) | MAMMARY MARKER | |
EP2115162A4 (en) | ADRB2-CANCER MARKER | |
ZA200907678B (en) | Polynucleotide markers | |
GB0922437D0 (en) | Hypoxia tumour markers | |
HK1147684A1 (en) | Targeted radiotherapy | |
GB0707933D0 (en) | Disease markers | |
GB0724412D0 (en) | Marker | |
EP2262951A4 (en) | TACTILE MARKER | |
ZA201200888B (en) | New tumor marker | |
AU320441S (en) | Marker | |
GB0714573D0 (en) | Marker gene | |
GB2477687B (en) | X-ray marker | |
GB0908071D0 (en) | Marker | |
GB0905964D0 (en) | Marker | |
GB0707671D0 (en) | Fiducial marker | |
GB0718496D0 (en) | Markers | |
EP2187216A4 (en) | NEW LIVER CANCER MARKER | |
GB0815935D0 (en) | Marker apparatus | |
GB0700550D0 (en) | Phsphorescent marker device | |
GB0703654D0 (en) | Sterimatic dose marker | |
GB0717319D0 (en) | Photoluminescent marker | |
GB0714398D0 (en) | Ground improvement | |
GB0701817D0 (en) | Marker | |
GB0804417D0 (en) | Markers |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |